NCT01431820View on ClinicalTrials.gov

Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

August 31, 2014

Conditions
Distal and Lateral Subungual Onychomycosis
Interventions
DRUG

Luliconazole Solution, 10%

Topical

DRUG

Vehicle Solution

Topical

Trial Locations (28)

11733

East Setauket

14623

Rochester

21214

Baltimore

24501

Lynchburg

33175

Miami

33180

Aventura

37215

Nashville

37922

Knoxville

40202

Louisville

45249

Cincinnati

47714

Evansville

48202

Detroit

53719

Madison

55432

Fridley

75243

Dallas

77840

College Station

78229

San Antonio

78759

Austin

80210

Denver

83704

Boise

84117

Salt Lake City

85050

Phoenix

87106

Albuquerque

90045

Los Angeles

92119

San Diego

92123

San Diego

97210

Portland

97223

Portland

Sponsors
All Listed Sponsors
lead

Topica Pharmaceuticals

INDUSTRY

NCT01431820 - Safety and Efficacy of Luliconazole Solution, 10% in Subjects With Mild to Moderate Onychomycosis | Biotech Hunter | Biotech Hunter